Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Inventurus Knowledge Solutions Ltd (IKS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544309 NSE: IKS IT - Software | Small Cap | Inventurus Knowledge Share Price
₹1,790.45 29.25 (1.66%)
As on 07-Sep'26 16:59
Inventurus Knowledge Solutions Ltd (IKS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544309 NSE: IKS IT - Software | Small Cap | Inventurus Knowledge Share Price
₹1,790.45 29.25 (1.66%)
As on 07-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹30,719 Cr.
Current Price
₹1,790.5
52-Week Low / High
₹1,262 / 1,934
TTM EPS
₹35.9
TTM Sales
₹1,647 Cr.
Book Value per Share
₹109
P/E Ratio
49.85
Lower than its 5-year historical median
Industry PE
21.5
Price to Book (P/B)
16.42
In line with its 5-year historical median
Price to Sales (P/S)
18.65
Lower than its 5-year historical median
EV/EBITDA
37.83
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
39.10%
Outperforms industry median
Return on Capital Employed (ROCE)
46.62%
Outperforms industry median
Return on Assets (ROA)
32.17%
Operating Profit Margin
46.3%
Net Profit Margin
37.99%
Gross Profit Margin
49%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
53.26%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
62.59%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
70.66%
Asset Quality
Promoter Holding
63.72%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,853 Cr.
Equity
₹17.2 Cr.
Face Value
₹1
All Time Low / High
₹1226.15 / 2190.00
Check Before You Invest
Quality
Very GoodValuation
FairCheck Valuation charts
Price Trend
Semi Strong
Is Inventurus Knowledge Solutions Ltd a good quality company?
Inventurus Knowledge Solutions Ltd is a good quality company, based on a consistently good multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Inventurus Knowledge Solutions Ltd performance compare with that of its Peers?
Revenue growth of Inventurus Knowledge Solutions Ltd vs industry peers?
Inventurus Knowledge Solutions Ltd revenue CAGR is 28.97%, compared to the industry median CAGR of 3.72%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Inventurus Knowledge Solutions Ltd?
Promoters hold 63.72% of the Inventurus Knowledge Solutions Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Inventurus Knowledge Solutions Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 12.5% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Inventurus Knowledge Solutions Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 29.8% | 20.5% | 65.5% | 65.4% | 51.4% | 47.9% | 50.7% | 50.5% | 37.7% | 46.6% | - |
| Value Creation Index ⓘ | 1.7 | 0.8 | 4.8 | 4.8 | 3.6 | 3.3 | 3.5 | 3.5 | 2.4 | 3.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 230 | 262 | 352 | 388 | 418 | 560 | 759 | 873 | 973 | 1,491 | 1,647 |
| Sales YoY Gr. | - | 13.6% | 34.6% | 10.1% | 7.8% | 34% | 35.5% | 15% | 11.5% | 53.3% | - |
| Adj EPS ⓘ | 1.2 | 0.9 | 5.4 | 7.6 | 8.5 | 12 | 16.5 | 20 | 19.4 | 31.3 | 35.9 |
| YoY Gr. | - | -27.4% | 498.9% | 41.4% | 11.3% | 41.8% | 37% | 21.6% | -3.1% | 61.5% | - |
| BVPS (₹) ⓘ | 1.9 | 3.4 | 9.7 | 13.6 | 22.4 | 30.1 | 37.7 | 48.2 | 69.9 | 100.1 | 109 |
| Adj Net Profit ⓘ | 20.6 | 14.5 | 86.9 | 124 | 139 | 204 | 277 | 339 | 330 | 535 | 616 |
| Cash Flow from Ops. ⓘ | 41.7 | 45.6 | 99.4 | 141 | 168 | 237 | 248 | 119 | 274 | 550 | - |
| Debt/CF from Ops. ⓘ | 1.5 | 1.1 | 0 | 0 | 0 | 0 | 0 | 1.2 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 23.1% | 29% | 25.3% | 53.3% | ||||
| Adj EPS ⓘ | 43.2% | 29.9% | 23.9% | 61.5% | ||||
| BVPSⓘ | 55.4% | 34.9% | 38.5% | 43.1% | ||||
| Share Price | - | - | - | 13.5% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 110.2 | 32.9 | 78.2 | 62.9 | 45.9 | 45.7 | 47.9 | 46.2 | 32.2 | 35.5 | 34.4 |
| Op. Profit Mgn % ⓘ | 18.2 | 14 | 28.8 | 35.7 | 39.7 | 41.7 | 42 | 45.6 | 43.7 | 46.3 | 48.9 |
| Net Profit Mgn % ⓘ | 9 | 5.6 | 24.7 | 32 | 33.2 | 36.4 | 36.5 | 38.8 | 34 | 35.9 | 37.4 |
| Debt to Equity ⓘ | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 | - |
| Working Cap Days ⓘ | 119 | 99 | 83 | 101 | 118 | 116 | 93 | 104 | 141 | 130 | 65 |
| Cash Conv. Cycle ⓘ | 63 | 29 | 6 | 6 | 8 | 7 | 8 | 40 | 77 | 66 | 37 |
Valuation of Inventurus Knowledge - Standalone
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 230 | 262 | 352 | 388 | 418 | 560 | 759 | 873 | 973 | 1,491 |
| Operating Expenses > ⓘ + | 189 | 225 | 253 | 252 | 252 | 329 | 444 | 478 | 548 | 801 |
| Operating Profit > ⓘ | 41 | 36 | 100 | 135 | 166 | 231 | 316 | 394 | 425 | 691 |
| Operating Profit Margin (%) | 18.0% | 13.9% | 28.3% | 35.0% | 39.6% | 41.3% | 41.6% | 45.2% | 43.6% | 46.3% |
| Other Income > ⓘ + | 1 | 12 | 24 | 31 | 16 | 21 | 28 | 33 | 17 | 52 |
| Interest > ⓘ | 6 | 6 | 4 | 7 | 7 | 6 | 5 | 16 | 11 | 12 |
| Depreciation > ⓘ | 15 | 28 | 33 | 36 | 26 | 19 | 20 | 22 | 29 | 37 |
| Profit Before Tax > ⓘ | 20 | 14 | 86 | 123 | 148 | 208 | 288 | 390 | 402 | 693 |
| Tax > ⓘ | 0 | 0 | 0 | 1 | 9 | 19 | 34 | 53 | 70 | 127 |
| Profit After Tax | 20 | 14 | 86 | 122 | 139 | 189 | 253 | 337 | 332 | 567 |
| PAT Margin (%) | 8.8% | 5.5% | 24.4% | 31.5% | 33.3% | 33.7% | 33.4% | 38.6% | 34.1% | 38.0% |
| Adjusted EPS (₹) | 1.2 | 0.9 | 5.3 | 7.5 | 8.5 | 11.1 | 15.1 | 19.9 | 19.5 | 33.2 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 15.80% | 14% | 48.50% | 66.40% | 50.20% | 0% | 0% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 31 | 54 | 156 | 221 | 367 | 510 | 635 | 815 | 1,190 | 1,708 | |
| Debt + | 42 | 38 | 1 | 0 | 0 | 0 | 0 | 138 | 0 | 11 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 8 | 24 | 8 | 19 | 8 | 16 | 21 | 16 | 31 | 47 | |
| Others Liabilities ⓘ | 76 | 40 | 27 | 83 | 64 | 100 | 86 | 146 | 140 | 395 | |
| Total Liabilities ⓘ | 158 | 155 | 193 | 323 | 440 | 626 | 741 | 1,116 | 1,361 | 2,161 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 42 | 81 | 52 | 90 | 72 | 63 | 49 | 116 | 101 | 146 | |
| CWIP ⓘ | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 3 | |
| Investments ⓘ | 4 | 5 | 6 | 5 | 16 | 16 | 19 | 473 | 734 | 1,352 | |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Receivables | 40 | 40 | 17 | 37 | 26 | 38 | 66 | 198 | 309 | 396 | |
| Cash Equivalents | 1 | 1 | 44 | 103 | 204 | 336 | 495 | 205 | 85 | 27 | |
| Others Assets ⓘ | 34 | 28 | 75 | 86 | 121 | 172 | 112 | 123 | 122 | 235 | |
| Total Assets ⓘ | 158 | 155 | 193 | 323 | 440 | 626 | 741 | 1,116 | 1,361 | 2,161 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 42 | 46 | 99 | 141 | 168 | 237 | 248 | 119 | 274 | 550 |
| Cash Flow From Investing Activity ⓘ + | -35 | -29 | -12 | -80 | -165 | -81 | -141 | -149 | -104 | -600 |
| Cash Flow From Financing Activity ⓘ + | -18 | -16 | -51 | -36 | -32 | -54 | -148 | -186 | 24 | -7 |
| Net Cash Flow ⓘ | -12 | 1 | 37 | 25 | -30 | 102 | -40 | -216 | 194 | -57 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 108.18 | 33.62 | 81.51 | 64.82 | 47.3 | 43.06 | 44.29 | 46.48 | 33.11 | 39.1 |
| ROCE (%) | 29.81 | 20.54 | 65.46 | 65.38 | 51.39 | 47.86 | 50.68 | 50.53 | 37.67 | 46.62 |
| Asset Turnover Ratio | 1.49 | 1.67 | 2.02 | 1.5 | 1.1 | 1.05 | 1.11 | 0.94 | 0.79 | 0.85 |
| PAT to CFO Conversion(x) | 2.1 | 3.29 | 1.15 | 1.16 | 1.21 | 1.25 | 0.98 | 0.35 | 0.83 | 0.97 |
| Working Capital Days | ||||||||||
| Receivable Days | 76.70 | 56.40 | 29.50 | 25.40 | 27.80 | 20.90 | 25 | 55.30 | 95.10 | 86.30 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Inventurus Knowledge Solutions Ltd FAQs
The current trading price of Inventurus Knowledge on 07-Sep-2026 16:59 is ₹1,790.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Sep-2026 the market cap of Inventurus Knowledge stood at ₹30,719.3 Cr
The latest P/E ratio of Inventurus Knowledge as of 06-Sep-2026 is 49.85.
The latest P/B ratio of Inventurus Knowledge as of 06-Sep-2026 is 16.42.
The 52-week high of Inventurus Knowledge is ₹1,933.8 and the 52-week low is ₹1,262.4.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Inventurus Knowledge is ₹1,647 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Inventurus Knowledge Solutions Ltd is a good quality company.
The key valuation ratios of Inventurus Knowledge Solutions Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Inventurus Knowledge Solutions Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Inventurus Knowledge Solutions Ltd
Inventurus Knowledge Solutions limited was incorporated on September 5, 2006, as a private limited company under the Companies Act, 1956, with the name, ‘Inventurus Knowledge Solutions Private Limited’ pursuant to a certificate of incorporation issued by the Registrar of Companies, Goa, Daman and Diu. pursuant to a special resolution dated June 10, 2019. On the conversion of the company to a public limited company, pursuant to a resolution passed by its Board on October 14, 2022 and its Shareholders on October 17, 2022, the name of the company was changed to ‘Inventurus Knowledge Solutions Limited’, consequent to which a fresh certificate of incorporation dated November 4, 2022, was issued by the Registrar of Companies (RoC).
The company is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It is a partner for outpatient and inpatient care organizations, enabling healthcare organizations deliver superior clinical care, improve population health outcomes, and transition to the ‘fee for value’ model while optimizing their revenue and reducing operating costs. With the evolution and consolidation of the healthcare industry, it provides solutions that address these increasing tasks, or 'chores', and enable healthcare delivery enterprises to focus on their core focus of healthcare, by taking over chores that are necessary to manage their business. It does this through a blend of pragmatic technology and global human capital, with the aim of enabling healthcare delivery enterprises deliver better, safer and cost-effective care.
It offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Outpatient service facilities, also known as ambulatory care, provide medical care without requiring admission to a hospital or other facility, and include observation, consultation, diagnosis, rehabilitation, intervention, and treatment services. Inpatient care, refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration.
Business area of the company
The company is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care.
Awards and accreditations
- 2019: Healthcare leadership award, 2019 by ABP news for contribution in the healthcare industry.
- 2020: L&D innovation and tech awards, 2020 by DISPRZ for best blended learning strategy.
- 2021: POSH awards, 2021 by KelpHR for being part of top 25 safest workplaces in India.
- 2021: TISS LeapVault award, 2021 in the best remote working program.
- 2022: 12th Aegis Graham Bell award, 2022 for being part of top three finalist in the category of innovation in Analytics.
- 2022: Technology Excellence award, 2022 for best data science project in the healthcare category.
History and milestones
- 2006: Incorporation of the company Investment by Rekha Jhunjhunwala, one of its Promoters.
- 2007: Onboarded its first client.
- 2009: Set up a new office space situated in an SEZ in Hyderabad, India.
- 2013: Set up a new office space situated in an SEZ in Mumbai, India.
- 2014: It turned EBITDA positive.
- 2015: Expanded its office space situated in an SEZ in Hyderabad, India.
- 2016: Registered ‘IKS Health’ brand and logo with the United States Patent and Trademark Office.
- 2022: Conversion of the company from Private Limited to Public Limited Company Crossed revenue of $100 million.
- 2023 Acquisition of Aquity Holdings, Inc. by IKS Inc.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
